Phaedon D. Zavras

548 total citations
24 papers, 336 citations indexed

About

Phaedon D. Zavras is a scholar working on Oncology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Phaedon D. Zavras has authored 24 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 7 papers in Epidemiology and 6 papers in Infectious Diseases. Recurrent topics in Phaedon D. Zavras's work include Cytomegalovirus and herpesvirus research (7 papers), COVID-19 Clinical Research Studies (4 papers) and Hyperglycemia and glycemic control in critically ill and hospitalized patients (3 papers). Phaedon D. Zavras is often cited by papers focused on Cytomegalovirus and herpesvirus research (7 papers), COVID-19 Clinical Research Studies (4 papers) and Hyperglycemia and glycemic control in critically ill and hospitalized patients (3 papers). Phaedon D. Zavras collaborates with scholars based in United States, Greece and Israel. Phaedon D. Zavras's co-authors include Marinos Kosmopoulos, Christina Piperi, Athanasios G. Papavassiliou, Leonidas Palaiodimos, Genovefa A. Papanicolaou, Sergio Giralt, Miguel‐Angel Perales, Weijia Li, Anat Stern and Yiqi Su and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Infectious Diseases.

In The Last Decade

Phaedon D. Zavras

22 papers receiving 326 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Phaedon D. Zavras United States	9	114	103	65	52	48	24	336
H.C.T. van Zaanen Netherlands	9	83 0.7×	22 0.2×	59 0.9×	30 0.6×	72 1.5×	17	389
И. Г. Бакулин Russia	10	223 2.0×	56 0.5×	26 0.4×	7 0.1×	34 0.7×	124	472
Xiuqi Wei China	8	123 1.1×	259 2.5×	75 1.2×	7 0.1×	21 0.4×	13	431
P. Gollapudi United States	7	61 0.5×	45 0.4×	15 0.2×	18 0.3×	30 0.6×	9	369
HyeJin Julia Kong Canada	10	208 1.8×	46 0.4×	25 0.4×	11 0.2×	83 1.7×	10	402
H.-D. Röher Germany	9	85 0.7×	30 0.3×	36 0.6×	16 0.3×	93 1.9×	16	340
Zeynep Canan Özdemir Türkiye	10	41 0.4×	17 0.2×	56 0.9×	28 0.5×	13 0.3×	59	315
Tatsuo Yoneda Japan	12	69 0.6×	35 0.3×	24 0.4×	22 0.4×	25 0.5×	75	430
B. Löffler Germany	8	115 1.0×	170 1.7×	45 0.7×	21 0.4×	5 0.1×	12	516
Hali̇l Yanardağ Türkiye	13	114 1.0×	25 0.2×	24 0.4×	55 1.1×	9 0.2×	40	481

Countries citing papers authored by Phaedon D. Zavras

Since Specialization

Citations

This map shows the geographic impact of Phaedon D. Zavras's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phaedon D. Zavras with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phaedon D. Zavras more than expected).

Fields of papers citing papers by Phaedon D. Zavras

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phaedon D. Zavras. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phaedon D. Zavras. The network helps show where Phaedon D. Zavras may publish in the future.

Co-authorship network of co-authors of Phaedon D. Zavras

This figure shows the co-authorship network connecting the top 25 collaborators of Phaedon D. Zavras. A scholar is included among the top collaborators of Phaedon D. Zavras based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phaedon D. Zavras. Phaedon D. Zavras is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Zavras, Phaedon D., Luciane T. Kagohara, Won Jin Ho, et al.. (2025). Spatial transcriptomic analysis of the ImmunoADAPT trial: Neoadjuvant endocrine therapy combined with palbociclib and avelumab in early-stage ER-positive breast cancer.. Journal of Clinical Oncology. 43(16_suppl).

2.

Zavras, Phaedon D., Ashley Cimino‐Mathews, Lisa K. Jacobs, et al.. (2024). Abstract PO1-01-09: Neoadjuvant endocrine therapy and avelumab with or without palbociclib in stage II/III endocrine receptor-positive breast cancer: the ImmunoADAPT trial. Cancer Research. 84(9_Supplement). PO1–1. 1 indexed citations

3.

Zavras, Phaedon D., Lilja B. Sólnes, Jenna VanLiere Canzoniero, et al.. (2024). A pilot study of early PET and biomarker dynamics in patients with stage 2 and 3 triple negative breast cancer treated with neoadjuvant response-adapted chemotherapy with pembrolizumab (NeoADAPT).. Journal of Clinical Oncology. 42(16_suppl). TPS624–TPS624. 1 indexed citations

4.

Zavras, Phaedon D., et al.. (2023). Understanding the Continuum between High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia. International Journal of Molecular Sciences. 24(5). 5018–5018. 8 indexed citations

5.

Zavras, Phaedon D., Yiqi Su, Jiaqi Fang, et al.. (2022). Outcomes of Refractory Cytomegalovirus Infection in the First Year after Allogeneic Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy. 28(7). 403.e1–403.e7. 6 indexed citations

6.

Su, Yiqi, Anat Stern, Tamara Nawar, et al.. (2022). Impact of Letermovir Primary Cytomegalovirus Prophylaxis on 1-Year Mortality After Allogeneic Hematopoietic Cell Transplantation: A Retrospective Cohort Study. Clinical Infectious Diseases. 75(5). 795–804. 32 indexed citations

7.

Zavras, Phaedon D., Vikas Mehta, Sanjay Goel, Kith Pradhan, & Henny H. Billett. (2021). Increased Incidence of Thrombosis in a Cohort of Cancer Patients with COVID-19. Acta Haematologica. 145(2). 152–159. 4 indexed citations

8.

Varrias, Dimitrios, Leonidas Palaiodimos, Prasanth Balasubramanian, et al.. (2021). The Use of Point-of-Care Ultrasound (POCUS) in the Diagnosis of Deep Vein Thrombosis. Journal of Clinical Medicine. 10(17). 3903–3903. 25 indexed citations

9.

Drakonaki, Eleni E., Maria Piagkou, Ioannis Koliarakis, et al.. (2021). Normal anatomy, variants and factors associated with the cervical vagus nerve topography: a high-resolution ultrasound study. Surgical and Radiologic Anatomy. 43(11). 1753–1764. 4 indexed citations

10.

Palaiodimos, Leonidas, Natalia Chamorro-Pareja, Dimitrios Karamanis, et al.. (2020). Diabetes is associated with increased risk for in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis comprising 18,506 patients. medRxiv. 13 indexed citations

11.

Fang, Jiaqi, Yiqi Su, Phaedon D. Zavras, et al.. (2020). Impact of Preemptive Therapy for Cytomegalovirus on Hospitalizations and Cost after Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 26(10). 1937–1947. 17 indexed citations

12.

Zavras, Phaedon D., Yiqi Su, Jiaqi Fang, et al.. (2020). Impact of Preemptive Therapy for Cytomegalovirus on Toxicities after Allogeneic Hematopoietic Cell Transplantation in Clinical Practice: A Retrospective Single-Center Cohort Study. Biology of Blood and Marrow Transplantation. 26(8). 1482–1491. 38 indexed citations

13.

Zavras, Phaedon D., et al.. (2020). Acute mastoiditis in infants aged six months or younger. The Journal of Laryngology & Otology. 134(8). 721–726. 1 indexed citations

14.

Chamorro-Pareja, Natalia, Dimitrios Karamanis, Phaedon D. Zavras, et al.. (2020). 377. Diabetes as a prognostic factor for mortality in Coronavirus Disease 19 (COVID-19): a systematic review and meta-analysis comprising 18,506 patients. Open Forum Infectious Diseases. 7(Supplement_1). S258–S258. 1 indexed citations

15.

Lee, Yeon Joo, Jiaqi Fang, Phaedon D. Zavras, et al.. (2020). Adenovirus Viral Kinetics and Mortality in Ex Vivo T Cell-Depleted Hematopoietic Cell Transplant Recipients With Adenovirus Infection From a Single Center. The Journal of Infectious Diseases. 222(7). 1180–1187. 9 indexed citations

16.

Palaiodimos, Leonidas, Natalia Chamorro-Pareja, Dimitrios Karamanis, et al.. (2020). Diabetes is associated with increased risk for in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis comprising 18,506 patients. HORMONES. 20(2). 305–314. 50 indexed citations

17.

Kosmopoulos, Marinos, et al.. (2019). Impact of advanced glycation end products (AGEs) signaling in coronary artery disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1865(3). 611–619. 89 indexed citations

18.

Zavras, Phaedon D., et al.. (2019). <p>Evaluating tisagenlecleucel and its potential in the treatment of relapsed or refractory diffuse large B cell lymphoma: evidence to date</p>. OncoTargets and Therapy. Volume 12. 4543–4554. 3 indexed citations

19.

Kosmopoulos, Marinos, et al.. (2018). Critical Role of IL-8 Targeting in Gliomas. Current Medicinal Chemistry. 25(17). 1954–1967. 25 indexed citations

20.

Tirosh, Amit, Phaedon D. Zavras, Elena Belyavskaya, et al.. (2017). Failure to Thrive in the Context of Carney Complex. Hormone Research in Paediatrics. 89(1). 38–46. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact